The presence of prostate cancer in MRI/ Fusion targeted biopsies for patients with PSA 1.0-2.0 ng/ml above NADIR after radical radiotherapy for localised prostate cancer.

Arvis Freimanis; Reinis Riekstiņš; Ansis Ozoliņš; Aleksandrs Dorogojs; Maija Radzina; Vilnis Lietuvietis

The presence of prostate cancer in MRI/ Fusion targeted biopsies for patients with PSA 1.0-2.0 ng/ml above NADIR after radical radiotherapy for localised prostate cancer.

Arvis Freimanis, Reinis Riekstiņš, Ansis Ozoliņš, Aleksandrs Dorogojs, Maija Radzina, Vilnis Lietuvietis

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Number of pages	1
Publication status	Published - 26 May 2023
Externally published	Yes
Event	8th Baltic meeting in conjunction with the European Association of Urology (EAU) - Radisson Blu Latvija Conference & Spa Hotel, Riga, Latvia Duration: 26 May 2023 → 27 May 2023 Conference number: 8 https://scientific-programme.uroweb.org/Baltic23/programme

Conference

Conference	8th Baltic meeting in conjunction with the European Association of Urology (EAU)
Abbreviated title	Baltic 23
Country/Territory	Latvia
City	Riga
Period	26/05/23 → 27/05/23
Internet address	https://scientific-programme.uroweb.org/Baltic23/programme

Field of Science*

3.2 Clinical medicine

Publication Type*

3.4. Other publications in conference proceedings (including local)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://urosource.uroweb.org/resource-centres/Baltic23/255193/abstract

Cite this

Freimanis, A., Riekstiņš, R., Ozoliņš, A., Dorogojs, A., Radzina, M., & Lietuvietis, V. (2023). The presence of prostate cancer in MRI/ Fusion targeted biopsies for patients with PSA 1.0-2.0 ng/ml above NADIR after radical radiotherapy for localised prostate cancer.. Abstract from 8th Baltic meeting in conjunction with the European Association of Urology (EAU) , Riga, Latvia. https://urosource.uroweb.org/resource-centres/Baltic23/255193/abstract

@conference{ada50118a51a4064917289a89128589e,

title = "The presence of prostate cancer in MRI/ Fusion targeted biopsies for patients with PSA 1.0-2.0 ng/ml above NADIR after radical radiotherapy for localised prostate cancer.",

author = "Arvis Freimanis and Reinis Riekstiņ{\v s} and Ansis Ozoliņ{\v s} and Aleksandrs Dorogojs and Maija Radzina and Vilnis Lietuvietis",

year = "2023",

month = may,

day = "26",

language = "English",

note = "8th Baltic meeting in conjunction with the European Association of Urology (EAU) , Baltic 23 ; Conference date: 26-05-2023 Through 27-05-2023",

url = "https://scientific-programme.uroweb.org/Baltic23/programme",

}

Freimanis, A, Riekstiņš, R, Ozoliņš, A, Dorogojs, A, Radzina, M & Lietuvietis, V 2023, 'The presence of prostate cancer in MRI/ Fusion targeted biopsies for patients with PSA 1.0-2.0 ng/ml above NADIR after radical radiotherapy for localised prostate cancer.', 8th Baltic meeting in conjunction with the European Association of Urology (EAU) , Riga, Latvia, 26/05/23 - 27/05/23. <https://urosource.uroweb.org/resource-centres/Baltic23/255193/abstract>

The presence of prostate cancer in MRI/ Fusion targeted biopsies for patients with PSA 1.0-2.0 ng/ml above NADIR after radical radiotherapy for localised prostate cancer. / Freimanis, Arvis; Riekstiņš, Reinis; Ozoliņš, Ansis et al.
2023. Abstract from 8th Baltic meeting in conjunction with the European Association of Urology (EAU) , Riga, Latvia.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - The presence of prostate cancer in MRI/ Fusion targeted biopsies for patients with PSA 1.0-2.0 ng/ml above NADIR after radical radiotherapy for localised prostate cancer.

AU - Freimanis, Arvis

AU - Riekstiņš, Reinis

AU - Ozoliņš, Ansis

AU - Dorogojs, Aleksandrs

AU - Radzina, Maija

AU - Lietuvietis, Vilnis

N1 - Conference code: 8

PY - 2023/5/26

Y1 - 2023/5/26

M3 - Abstract

T2 - 8th Baltic meeting in conjunction with the European Association of Urology (EAU)

Y2 - 26 May 2023 through 27 May 2023

ER -